Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG
Status:
Completed
Trial end date:
2020-08-19
Target enrollment:
Participant gender:
Summary
This clinical trial is a prospective, multicenter, self-controlled clinical study. In order
to meet the requirements of this plan, 130 breast cancer patients need the sentinel lymph
node biopsy with novel near-infarred fluorescence imaging system produced by Beijing digital
precision medical technology co., LTD. The fluorescence molecular imaging of indocyanine
green (ICG) on imaging detection and the control group, routine medical using methylene blue
test .The safety and efficacy of fluorescence and staining in sentinel lymph node biopsy of
breast cancer were compared.
Phase:
N/A
Details
Lead Sponsor:
Chinese Academy of Sciences
Collaborators:
Beijing Digital Precesion Medicine Company Beijing Friendship Hospital Cancer Institute and Hospital, Chinese Academy of Medical Sciences Tangshan People's Hospital The Second Hospital of Hebei Medical University